trending Market Intelligence /marketintelligence/en/news-insights/trending/17q4rr9Ho5WIm5NFRHkHIA2 content esgSubNav
In This List

Repros Therapeutics names president, CEO

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Repros Therapeutics names president, CEO

Repros Therapeutics Inc. appointed Larry Dillaha as the company's permanent president and CEO.

Dillaha, who previously held chief medical officer roles at Insys Therapeutics Inc. and Sciele Pharma Inc., will also fill a vacancy on the company's board.

Dillaha was performing the duties on an interim basis following the resignation of Joseph Podolski.